A detailed history of Cwm, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Cwm, LLC holds 495 shares of PRCT stock, worth $33,867. This represents 0.0% of its overall portfolio holdings.

Number of Shares
495
Previous 420 17.86%
Holding current value
$33,867
Previous $26,000 53.85%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$56.31 - $84.99 $4,223 - $6,374
75 Added 17.86%
495 $40,000
Q2 2024

Jul 09, 2024

BUY
$45.73 - $69.19 $823 - $1,245
18 Added 4.48%
420 $26,000
Q1 2024

Apr 05, 2024

BUY
$40.38 - $50.75 $16,232 - $20,401
402 New
402 $20,000
Q3 2023

Oct 11, 2023

BUY
$30.02 - $38.81 $120 - $155
4 Added 33.33%
16 $1,000
Q2 2023

Aug 03, 2023

BUY
$26.7 - $37.02 $26 - $37
1 Added 9.09%
12 $0
Q2 2022

Jul 28, 2022

BUY
$29.23 - $44.45 $321 - $488
11 New
11 $0

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.05B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.